News

gut.bmj2d
Colorectal cancer incidence after the first surveillance colonoscopy and the need for ongoing surveillance: a retrospective, cohort analysis
Background Recommendations for the first postpolypectomy surveillance colonoscopy (SC1), based on stratifying postpolypectomy colorectal cancer (CRC) risk, are well established. Limited data inform ...
gut.bmj2d
Increased human intestinal barrier permeability plasma biomarkers zonulin and FABP2 correlated with plasma LPS and altered gut microbiome in anxiety or depression
Correspondence to Dr Bruce R Stevens, Department of Physiology & Functional Genomics, University of Florida College ofMedicine, 32610-0274, Gainesville, Florida, USA; stevensb{at}ufl.edu But common to ...
gut.bmj3d
Stool microRNA profiles reflect different dietary and gut microbiome patterns in healthy individuals
1 Italian Institute for Genomic Medicine (IIGM), c/o IRCCS Candiolo, Torino, Italy Objectives MicroRNA (miRNA) profiles have been evaluated in several biospecimens in relation to common diseases for ...
gut.bmj4d
Identification and genetic manipulation of human and mouse oesophageal stem cells
1 Stanford Cancer Institute and Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, California, USA Objective Human oesophageal stem cell ...
gut.bmj4d
The Asia-Pacific Colorectal Screening score: a validated tool that stratifies risk for colorectal advanced neoplasia in asymptomatic Asian subjects
1 Department of Medicine, National University of Singapore, Singapore, Singapore 2 Department of Internal Medicine, National Taiwan University, Taipei, Taiwan 3 Department of Medicine and Therapeutics ...
gut.bmj4d
Integrated metagenomic and metabolomic analysis reveals distinct gut-microbiome-derived phenotypes in early-onset colorectal cancer
Correspondence to Dr Yanlei Ma, Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China; yanleima{at}fudan.edu.cn Objective The incidence of early-onset ...
gut.bmj5d
Agonist that activates the µ-opioid receptor in acidified microenvironments inhibits colitis pain without side effects
Correspondence to Professor Nigel W Bunnett, Department of Molecular Pathobiology, New York University College of Dentistry, New York, NY 10010, USA; nwb2{at}nyu.edu Objective The effectiveness of ...
Gut5d
Gene score to quantify systemic inflammation in patients with acutely decompensated cirrhosis
Background and aims Quantifying systemic inflammation (SI) in acutely decompensated cirrhosis (ADC) is of major importance ...
Gut5d
Endoscopic mucosal and submucosal cutting for long benign oesophageal strictures
The treatment of long benign oesophageal strictures remains a clinical challenge. We present a novel endoscopic technique ...
gut.bmj6d
PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis
1 Division of Gastroenterology and Hepatology, Mayo Clinic and Foundation, Rochester, MN, USA 2 Division of Biostatistics, Mayo Clinic and Foundation, Rochester, MN, USA Correspondence to: Dr E V ...
Gut6d
Reply to ‘Critical appraisal of the HELIOS study on surveillance in IBD patients’
We thank Dr Yang and colleagues for their interest in the HELIOS trial and their thoughtful appraisal of our findings.1 2 Yang et al highlight the possibility that heterogeneity in endoscopist ...
gut.bmj6d
Aberrant gut microbiota alters host metabolome and impacts renal failure in humans and rodents
Objective Patients with renal failure suffer from symptoms caused by uraemic toxins, possibly of gut microbial origin, as deduced from studies in animals. The aim of the study is to characterise ...